LINDSEY GRIESER: Open Payments
NPI 1649827965 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,222 in 163 payments from 21 companies in 2025. Trend: 2023 $1,212 · 2024 $2,483 · 2025 $3,222
Food & beverage: $2,963Consulting: $175Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $908 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 40 | $728 |
| Janssen Biotech, Inc. | 12 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $201 |
| Madrigal Pharmaceuticals | 9 | $181 |
| GENZYME CORPORATION | 7 | $181 |
| Mallinckrodt Hospital Products Inc. | 4 | $142 |
| Ardelyx, Inc. | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Ipsen Biopharmaceuticals, Inc | 4 | $78 |
Products named: XIFAXAN, DUPIXENT, TREMFYA, RINVOQ, LINZESS, ENTYVIO, REZDIFFRA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
